PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery
Status:
Completed
Trial end date:
2017-10-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness and safety of a new peptide-based
coagulant, PeproStat. The study drug will be applied to patients undergoing liver/soft tissue
surgery, vascular surgery or spine surgery. The speed of action of the new coagulant, that is
applied with a gelatin sponge, will be compared to the same sponge but with saline (a
commonly used standard of care).